semaglutide pdufa Novo says it's submitted obesity pill for FDA approval FDA Approves Oral Semaglutide (Rybelsus)

In the context of white adipogenic differentiation, commonly impaired in T2D, semaglutide increased adipocyte numbers and induced a shift toward a more lipolytic phenotype, as indicated by a reduction in medium-sized lipid droplets

Compound 6 exhibited only marginal efficacy of 16% and 7% decrease in worm and egg burdens, respectively

Biochemistry 48 , 61666174 (2009)

Ullsten, S., Danielsson, R., Bckstrm, D., Sjberg, P

11 When glucagon levels rise, the liver tends to make less new fat and hold on to less fat overall

Head-to-head comparison studies are needed, but the Triple G weight loss drug may be the best GLP-1 for weight loss and much more